231 related articles for article (PubMed ID: 11801790)
1. Cytokeratins as markers of follicular differentiation: an immunohistochemical study of trichoblastoma and basal cell carcinoma.
Kurzen H; Esposito L; Langbein L; Hartschuh W
Am J Dermatopathol; 2001 Dec; 23(6):501-9. PubMed ID: 11801790
[TBL] [Abstract][Full Text] [Related]
2. Cytokeratin expression in trichoblastic fibroma (small nodular type trichoblastoma), trichoepithelioma and basal cell carcinoma.
Yamamoto O; Asahi M
Br J Dermatol; 1999 Jan; 140(1):8-16. PubMed ID: 10215762
[TBL] [Abstract][Full Text] [Related]
3. Trichoblastoma and basal cell carcinoma are neoplasms with follicular differentiation sharing the same profile of cytokeratin intermediate filaments.
Schirren CG; Rütten A; Kaudewitz P; Diaz C; McClain S; Burgdorf WH
Am J Dermatopathol; 1997 Aug; 19(4):341-50. PubMed ID: 9261468
[TBL] [Abstract][Full Text] [Related]
4. Tricholemmal carcinoma in continuity with trichoblastoma within nevus sebaceus.
Misago N; Narisawa Y
Am J Dermatopathol; 2002 Apr; 24(2):149-55. PubMed ID: 11979076
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical expression of cytokeratin 15, cytokeratin 19, follistatin, and Bmi-1 in basal cell carcinoma.
Kim HC; Sohng SH; Shin DH; Choi JS; Bae YK
Int J Dermatol; 2016 Jan; 55(1):36-44. PubMed ID: 26739632
[TBL] [Abstract][Full Text] [Related]
6. PHLDA1, a follicular stem cell marker, differentiates clear-cell/granular-cell trichoblastoma and clear-cell/granular cell basal cell carcinoma: a case-control study, with first description of granular-cell trichoblastoma.
Battistella M; Peltre B; Cribier B
Am J Dermatopathol; 2014 Aug; 36(8):643-50. PubMed ID: 23719479
[TBL] [Abstract][Full Text] [Related]
7. [Not Available].
Cribier B
Ann Dermatol Venereol; 2018 Nov; 145 Suppl 5():VS3-VS11. PubMed ID: 30477681
[TBL] [Abstract][Full Text] [Related]
8. Expression of type I hair keratins in follicular tumours.
Cribier B; Peltre B; Langbein L; Winter H; Schweizer J; Grosshans E
Br J Dermatol; 2001 May; 144(5):977-82. PubMed ID: 11359384
[TBL] [Abstract][Full Text] [Related]
9. CD10, TDAG51, CK20, AR, INSM1, and Nestin Expression in the Differential Diagnosis of Trichoblastoma and Basal Cell Carcinoma.
Leblebici C; Bambul Sığırcı B; Kelten Talu C; Koca SB; Huq GE
Int J Surg Pathol; 2019 Feb; 27(1):19-27. PubMed ID: 29938548
[TBL] [Abstract][Full Text] [Related]
10. Two Novel Biomarker Candidates for Differentiating Basal Cell Carcinoma from Trichoblastoma; Asprosin and Meteorine Like Peptide.
Kocaman N; Yuksel EI; Demir B; Calik I; Cicek D
Tissue Cell; 2022 Jun; 76():101752. PubMed ID: 35144124
[TBL] [Abstract][Full Text] [Related]
11. Merkel cell-poor trichoblastoma with basal cell carcinoma-like foci.
Misago N; Satoh T; Miura Y; Nagase K; Narisawa Y
Am J Dermatopathol; 2007 Jun; 29(3):249-55. PubMed ID: 17519622
[TBL] [Abstract][Full Text] [Related]
12. Expression of drebrin, an actin binding protein, in basal cell carcinoma, trichoblastoma and trichoepithelioma.
Mizutani Y; Iwamoto I; Kanoh H; Seishima M; Nagata K
Histol Histopathol; 2014 Jun; 29(6):757-66. PubMed ID: 24346822
[TBL] [Abstract][Full Text] [Related]
13. A rippled-pattern trichoblastoma: an immunohistochemical study.
Yamamoto O; Hisaoka M; Yasuda H; Nishio D; Asahi M
J Cutan Pathol; 2000 Oct; 27(9):460-5. PubMed ID: 11028817
[TBL] [Abstract][Full Text] [Related]
14. Basal cell carcinoma cells resemble follicular matrix cells rather than follicular bulge cells: immunohistochemical and ultrastructural comparative studies.
Kore-eda S; Horiguchi Y; Ueda M; Toda K; Imamura S
Am J Dermatopathol; 1998 Aug; 20(4):362-9. PubMed ID: 9700374
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical study of angiotensin receptors in human anagen hair follicles and basal cell carcinoma.
Takeda H; Katagata Y; Kondo S
Br J Dermatol; 2002 Aug; 147(2):276-80. PubMed ID: 12174099
[TBL] [Abstract][Full Text] [Related]
16. Basaloid tumors in nevus sebaceus revisited: the follicular stem cell marker PHLDA1 (TDAG51) indicates that most are basal cell carcinomas and not trichoblastomas.
Sellheyer K; Cribier B; Nelson P; Kutzner H; Rütten A
J Cutan Pathol; 2013 May; 40(5):455-62. PubMed ID: 23489134
[TBL] [Abstract][Full Text] [Related]
17. CD34 and BerEP4 Are Helpful to Distinguish Basaloid Tricholemmoma From Basal Cell Carcinoma.
Turnbull N; Ghumra W; Mudaliar V; Vella J; Sanders DSA; Taibjee S; Carr R
Am J Dermatopathol; 2018 Aug; 40(8):561-566. PubMed ID: 29570129
[TBL] [Abstract][Full Text] [Related]
18. Basaloid tumors arising from seborrheic keratosis: Malignant basal cell carcinoma or benign basaloid follicular hamartomatous proliferation?
Flordelis JO; Shen YC; Wu YH
J Cutan Pathol; 2020 Mar; 47(3):207-218. PubMed ID: 31682281
[TBL] [Abstract][Full Text] [Related]
19. Histologic Mimics of Basal Cell Carcinoma.
Stanoszek LM; Wang GY; Harms PW
Arch Pathol Lab Med; 2017 Nov; 141(11):1490-1502. PubMed ID: 29072946
[TBL] [Abstract][Full Text] [Related]
20. Basaloid neoplasms in nevus sebaceus.
Kaddu S; Schaeppi H; Kerl H; Soyer HP
J Cutan Pathol; 2000 Aug; 27(7):327-37. PubMed ID: 10917159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
